- Home
- SFST vs AQST Comparison
SFST vs AQST Comparison
Compare SFST & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- AQST
- Stock Information
- Founded
- SFST 1999
- AQST 2004
- Country
- SFST United States
- AQST United States
- Employees
- SFST N/A
- AQST N/A
- Industry
- SFST Major Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- SFST Finance
- AQST Health Care
- Exchange
- SFST Nasdaq
- AQST Nasdaq
- Market Cap
- SFST 292.1M
- AQST 285.4M
- IPO Year
- SFST 1999
- AQST 2018
- Fundamental
- Price
- SFST $36.98
- AQST $3.10
- Analyst Decision
- SFST
- AQST Strong Buy
- Analyst Count
- SFST 0
- AQST 8
- Target Price
- SFST N/A
- AQST $10.38
- AVG Volume (30 Days)
- SFST 19.1K
- AQST 1.5M
- Earning Date
- SFST 01-28-2025
- AQST 03-04-2025
- Dividend Yield
- SFST N/A
- AQST N/A
- EPS Growth
- SFST N/A
- AQST N/A
- EPS
- SFST 1.73
- AQST N/A
- Revenue
- SFST $90,166,000.00
- AQST $58,900,000.00
- Revenue This Year
- SFST N/A
- AQST $18.44
- Revenue Next Year
- SFST $13.55
- AQST N/A
- P/E Ratio
- SFST $21.38
- AQST N/A
- Revenue Growth
- SFST 3.18
- AQST 22.56
- 52 Week Low
- SFST $24.98
- AQST $2.24
- 52 Week High
- SFST $45.91
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- SFST 43.28
- AQST 34.77
- Support Level
- SFST $35.48
- AQST $2.96
- Resistance Level
- SFST $36.54
- AQST $3.30
- Average True Range (ATR)
- SFST 1.02
- AQST 0.21
- MACD
- SFST -0.05
- AQST 0.01
- Stochastic Oscillator
- SFST 50.28
- AQST 16.87
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the "FDIC"), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.